# The Germinal Peptide Eye Drops in Healthy Volunteers in a Clinical Study

> **NCT03967548** · PHASE1 · COMPLETED · sponsor: **Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.** · enrollment: 106 (actual)

## Conditions studied

- Corneal Defect

## Interventions

- **DRUG:** Germinal peptide eye drops

## Key facts

- **NCT ID:** NCT03967548
- **Lead sponsor:** Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-09
- **Primary completion:** 2021-05-16
- **Final completion:** 2021-06-15
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2021-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03967548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03967548, "The Germinal Peptide Eye Drops in Healthy Volunteers in a Clinical Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03967548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*